ECU
GILD icon

Eisler Capital (US)’s Gilead Sciences GILD Stock Holding History

Eisler Capital (US)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,276
Closed -$419K – 648
2024
Q1 		$460K Buy
+6,276
New +$483K 0.01% 481
2023
Q4 		– Sell
-15,000
Closed -$1.17M – 328
2023
Q3 		$1.12M Buy
+15,000
New +$1.15M 0.03% 296

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Eisler Capital (US)'s GILD Position: Q2 2024 in Review

Eisler Capital (US) sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 6,276 shares — an estimated $419K sold.

Eisler Capital (US) first reported a position in GILD in Q3 2023 and held it in 2 quarters. The position peaked at $1.12M in Q3 2023. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Eisler Capital (US) reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 6,276 Gilead Sciences shares in Q2 2024, an estimated $419K.
  • Eisler Capital (US) first reported a position in Gilead Sciences in Q3 2023 and held it in 2 quarters.
  • Eisler Capital (US)'s Gilead Sciences position peaked at $1.12M in Q3 2023.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Eisler Capital (US)'s 13F filing for Q2 2024, filed 13 Aug 2024.